Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and antitumor effect of oncolytic and helper-dependent adenoviruses expressing interleukin-12 variants in a hamster pancreatic cancer model

Published:2015-05-04 Issue:9 Volume:22 Page:696-706
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Poutou J,Bunuales M,Gonzalez-Aparicio M,Garcia-Aragoncillo E,Quetglas J I,Casado R,Bravo-Perez C,Alzuguren P,Hernandez-Alcoceba R

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt201545.pdf

Reference42 articles.

1. Jinushi M, Tahara H . Cytokine gene-mediated immunotherapy: current status and future perspectives. Cancer Sci 2009; 100: 1389–1396.

2. Lichty BD, Breitbach CJ, Stojdl DF, Bell JC . Going viral with cancer immunotherapy. Nat Rev Cancer 2014; 14: 559–567.

3. Tong AW, Senzer N, Cerullo V, Templeton NS, Hemminki A, Nemunaitis J . Oncolytic viruses for induction of anti-tumor immunity. Curr Pharm Biotechnol 2012; 13: 1750–1760.

4. Andtbacka RHI, Collichio FA, Amatruda T, Senzer NN, Chesney J, Delman KA, Spitler LE, Puzanov I, Doleman S, Ye Y, Vanderwalde AM, Coffin R, Kaufman H . OPTiM: a randomized phase III trial of talimogene laherparepvec (T-VEC) versus subcutaneous (SC) granulocyte-macrophage colony-stimulating factor (GM-CSF) for the treatment (tx) of unresected stage IIIB/C and IV melanoma. J Clin Oncol 2013; 31 (Suppl): aLBA9008.

5. Heo J, Reid T, Ruo L, Breitbach CJ, Rose S, Bloomston M et al. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. Nat Med 2013; 19: 329–336.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA-Mediated Mechanisms in the Generation of Effective and Safe Oncolytic Viruses;Pharmaceutics;2024-07-25

2. Recent Advancement in Stem Cell Therapies for Cancer Treatment;Comprehensive Hematology and Stem Cell Research;2024

3. Syrian hamster as an ideal animal model for evaluation of cancer immunotherapy;Frontiers in Immunology;2023-02-27

4. Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses;Expert Opinion on Biological Therapy;2022-11-02

5. Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches;Pharmaceutics;2022-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3